Gangwon, South Korea

Hye In Kim

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Abtlas Co., Ltd.. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye In Kim. Retrieved from https://idiyas.com/inventor/hye-in-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hye In Kim: Innovator in Protein Engineering

Introduction

Hye In Kim, a notable inventor based in Gangwon-do, South Korea, has made significant contributions to the field of protein engineering. With two patented inventions to his name, Kim is at the forefront of innovative approaches to antibody development and protein purification.

Latest Patents

Kim's most recent patents include a "Protein combination-based Fv library and preparation method therefor" and a "Method for refining protein including self-cutting cassette and use thereof." The first invention relates to constructing an Fv library based on a combination of proteins, which allows for individual analysis of members' functions. This groundbreaking method enables desired Fv antibodies to be screened without the need for target antigen preparation, thus drastically reducing the number of protein purification processes, costs, and time compared to traditional DNA-based libraries.

In his second patent, Kim introduces a self-cleaving fusion protein, which integrates a target protein, a specific peptide sequence (LPXTG), a cleaving domain of Sortase A, and a tag, all arranged sequentially from the amino terminal. The invention encompasses a method for refining a target protein through the cultivation, dissolution, and purification of transformed cells, as well as a technique for preparing therapeutic antibody-drug conjugates using the purification method.

Career Highlights

Currently, Hye In Kim is affiliated with Abtlas Co., Ltd., where he applies his expertise in protein engineering and antibody development. His work at Abtlas Co., Ltd. exemplifies the commitment to advancing biotechnological solutions and addressing complex challenges in therapeutic drug development.

Collaborations

Kim collaborates closely with colleagues Byeong Doo Song and Jee Sun Yun, leveraging their combined expertise to push the boundaries of research and innovation in protein engineering.

Conclusion

Hye In Kim’s contributions to the invention of advanced protein engineering methods have opened new avenues for research and development in the field. Through his innovative patents and collaborations, he continues to impact the biotechnology landscape significantly, embodying the spirit of creativity and scientific inquiry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…